Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: A multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction
Titel:
Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: A multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction
Auteur:
Nyolczas, Noémi Gyöngyösi, Mariann Beran, Gilbert Dettke, Markus Graf, Senta Sochor, Heinz Christ, Günther Édes, István Balogh, László Krause, Korff T. Jaquet, Kai Kuck, Karl-Heinz Benedek, Imre Hintea, Theodora Kiss, Róbert Préda, István Kotevski, Vladimir Pejkov, Hristo Dudek, Darius Heba, Grzegorz Sylven, Christer Charwat, Silvia Jacob, Ronaldo Maurer, Gerald Lang, Irene Glogar, Dietmar
Verschenen in:
American heart journal
Paginering:
Jaargang 153 (2007) nr. 2 pagina's 2.119997881E9 p.